Ralaniten triacetate
Ralaniten triacetate (EPI-506), a precursor of Ralaniten, is a first-of-its-kind, orally active androgen receptor N-terminal structural domain (AR-NTD) inhibitor with anticancer activity and can be used to study prostate and breast cancer.
Product Specifications
CAS Number
1637573-04-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
521
Molecular Formula
C27H33ClO8
Notes
Research use only, not for human use.
Receptor
Androgen Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1359283-02 0.05 mg (Baculovirus)
Recombinant Mouse Synaptotagmin-15 (Syt15), partial
Ask
View Details MBS1359283-04 0.05 mg (Mammalian-Cell)
Recombinant Mouse Synaptotagmin-15 (Syt15), partial
Ask
View Details